CS
PJP icon

Credit Suisse’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Credit Suisse’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-9,985
Closed -$759K – 3235
2023
Q1 		$759K Sell
9,985
-6,104
-38% -$471K ﹤0.01% 2488
2022
Q4 		$1.26M Buy
16,089
+15,313
+1,973% +$1.18M ﹤0.01% 2177
2022
Q3 		$55K Hold
776
– – ﹤0.01% 3525
2022
Q2 		$58K Buy
+776
New +$58.8K ﹤0.01% 3617
2021
Q4 		– Sell
-17,727
Closed -$1.37M – 4637
2021
Q3 		$1.37M Sell
17,727
-17,207
-49% -$1.39M ﹤0.01% 3101
2021
Q2 		$2.81M Buy
34,934
+10,362
+42% +$823K ﹤0.01% 2567
2021
Q1 		$1.94M Buy
+24,572
New +$1.92M ﹤0.01% 2845
2017
Q4 		– Sell
-6,190
Closed -$405K – 4160
2017
Q3 		$405K Hold
6,190
– – ﹤0.01% 3605
2017
Q2 		$389K Sell
6,190
-44,349
-88% -$2.66M ﹤0.01% 3318
2017
Q1 		$2.97M Sell
50,539
-2,840
-5% -$166K ﹤0.01% 2050
2016
Q4 		$2.99M Buy
53,379
+39,919
+297% +$2.3M ﹤0.01% 2101
2016
Q3 		$830K Sell
13,460
-46,852
-78% -$3.07M ﹤0.01% 3106
2016
Q2 		$3.82M Buy
60,312
+30,442
+102% +$1.91M ﹤0.01% 1826
2016
Q1 		$1.79M Buy
29,870
+12,162
+69% +$744K ﹤0.01% 2283
2015
Q4 		$1.24M Buy
17,708
+10,700
+153% +$759K ﹤0.01% 2649
2015
Q3 		$465K Buy
7,008
+1
+0% +$78 ﹤0.01% 3450
2015
Q2 		$549K Sell
7,007
-1,641
-19% -$128K ﹤0.01% 3651
2015
Q1 		$661K Buy
8,648
+1,847
+27% +$136K ﹤0.01% 3334
2014
Q4 		$452K Sell
6,801
-2,800
-29% -$186K ﹤0.01% 3785
2014
Q3 		$611K Sell
9,601
-97
-1% -$5.99K ﹤0.01% 3481
2014
Q2 		$592K Sell
9,698
-1,000
-9% -$58K ﹤0.01% 3707
2014
Q1 		$606K Sell
10,698
-5,787
-35% -$329K ﹤0.01% 3558
2013
Q4 		$882K Hold
16,485
– – ﹤0.01% 3373
2013
Q3 		$759K Sell
16,485
-834
-5% -$38.1K ﹤0.01% 3177
2013
Q2 		$732K Buy
+17,319
New +$721K ﹤0.01% 3032

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $687M AUM 24.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Credit Suisse's PJP Position: Q2 2023 in Review

Credit Suisse sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2023, closing a stake of 9,985 shares — an estimated $759K sold.

Credit Suisse first reported a position in PJP in Q2 2013 and held it in 25 quarters. The position peaked at $3.82M in Q2 2016. 87 funds tracked by Wall St. Rank hold PJP as of Q2 2023.

  • Credit Suisse reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2023 after selling out during the quarter.
  • Credit Suisse sold 9,985 Invesco Pharmaceuticals ETF shares in Q2 2023, an estimated $759K.
  • Credit Suisse first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 25 quarters.
  • Credit Suisse's Invesco Pharmaceuticals ETF position peaked at $3.82M in Q2 2016.
  • 87 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2023.

Based on Credit Suisse's 13F filing for Q2 2023, filed 11 Aug 2023.